TRIM22 and infection: As TRIM22 has been reported to act as a direct antiviral effector protein of IAV infection through the targeted ubiquitination and proteasome-dependent degradation of NP (Di Pietro et al., 2013; Pagani et al., 2018), we reasoned that the constitutive expression of this antiviral effector protein might provide cells with an immediate level of protection against infection.